摘要
目的:分析舒肝明目汤口服对青光眼睫状体炎综合征临床疗效、视力指标及角膜后沉着物(Keratic Precipitates,KP)数目的影响。方法:选择2018年8月-2020年8月青岛大学附属威海市立第二医院收治的青光眼睫状体炎综合征患者90例,按随机数字表法分为两组,对照组45例使用常规药物治疗,研究组45例则在对照组治疗基础之上使用舒肝明目汤口服治疗,对两组临床疗效、视力指标及KP数目进行比较。结果:研究组临床总有效率显著高于对照组(P <0.05);研究组的眼压和KP数目比对照组低,视力明显比对照组高(P <0.05);研究组房水前列腺素E;(Prostaglandin E_(2),PGE_(2))水平比对照组低(P <0.05)。结论:青光眼睫状体炎综合征患者使用舒肝明目汤治疗,可改善患者KP数目及眼压,提升其视力水平及治疗效果,临床上值得推广使用。
Objective:To analyze the influences of the Shugan Mingmu decoction(舒肝明目汤)on clinical efficacy,visual acuity index and KP number of glaucoma and cyclitis syndrome patients.Methods:90 cases from August 2018 to August 2020 were selected and divided into two groups according to the random number table method.45 cases in the control group were treated with conventional medicines,and 45 cases in the study group were given conventional medicines plus the Shugan Mingmu decoction.Results:The total efficiency in the study group was significantly higher than the control group(P<0.05).The intraocular pressure and KP number in the study group were lower than those in the control group,and the visual acuity in the study group was significantly higher than the control group(P<0.05).The level of PGE2 in aqueous humor of patients in the study group was lower than the control group(P<0.05).Conclusion:The Shugan Mingmu decoction on glaucoma and cyclitis syndrome can ameliorate the number of KP and intraocular pressure,and can improve visual acuity and clinical effect.It is worth popularizing clinically.
出处
《中医临床研究》
2022年第7期79-81,共3页
Clinical Journal Of Chinese Medicine
关键词
舒肝明目汤
青光眼睫状体炎综合征
视力指标
角膜后沉着物数目
The Shugan Mingmu decoction
Glaucoma and cyclitis syndrome
Visual acuity index
The number of keratic precipitates
